Dakota Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Dakota Wealth Management's IBB Position: Q2 2026 in Review
Dakota Wealth Management increased its iShares Biotechnology ETF (IBB) stake by 2.6% in Q2 2026, buying an estimated $45.5K and bringing the position to 10,607 shares worth $2.02M. The position accounts for 0.04% of the portfolio, ranked #309.
Dakota Wealth Management first reported a position in IBB in Q2 2018 and has held it in 16 quarters since. The position peaked at $2.54M in Q3 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Dakota Wealth Management held 10,607 shares of iShares Biotechnology ETF worth $2.02M as of Q2 2026.
- Dakota Wealth Management bought 265 iShares Biotechnology ETF shares in Q2 2026, an estimated $45.5K.
- iShares Biotechnology ETF made up 0.04% of Dakota Wealth Management's portfolio in Q2 2026, its #309 holding.
- Dakota Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2018 and has held it in 16 quarters since.
- Dakota Wealth Management's iShares Biotechnology ETF position peaked at $2.54M in Q3 2024.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Dakota Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.